Lukasz Bugaj, Ph.D., Assistant Professor of Bioengineering and IRM faculty member, is the lead author on a paper published in Science that examines the impact of cancer mutations and drugs on signal pathways, specifically the Ras-Erk pathway. Read the full paper here.
This paper was featured in a Perspective piece by Walter Kolch, M.D. and Christina Kiel, Ph.D., which you can read here.
Bugaj, L. J., A. J. Sabnis, A. Mitchell, J. E. Garbarino, J. E. Toettcher, T. G. Bivona, and W. A. Lim. 2018. “Cancer Mutations and Targeted Drugs can Disrupt Dynamic Signal Encoding by the Ras-Erk Pathway.” Science 361 (6405) (Aug 31,): eaao3048. doi:10.1126/science.aao3048. https://www.ncbi.nlm.nih.gov/pubmed/30166458.